Tapentadol (Nucynta) placed in CII -- a sad...

resorcinol · 03-23-2009, 08:16 PM

...loss for hope of a little progressivism with scheduling for new psychoactive drugs.

The drug is probably somewhere between hydrocodone and O-desmethyltramadol in potency as a mu agonist, so I guess if the DEA follows their own precedent this scheduling makes sense. However, it's such BS for those of us hoping for more lenient scheduling. It seems like the fuckheads at the DEA make anything with no dose ceiling that is an opioid or stimulant CII, period, despite the wide disparity in fun potential among CII drugs!

PURE codeine and oxymorphone are in the same schedule (CII). Whoops, I was even mistaken above, an opioid prodrug DID find its way into CII (codeine by itself, no APAP or other add on drug in the formulation). That's just ridiculous.

I was expecting CIII and hoping for CIV. When I saw that it got CII, I was floored. So much for patients just entering CP treatment having a drug option that has not yet been stigmatized to all hell by the media --- simply having CII attached to it is enough to spook doctors.

It will be undergoing review / appeal (lets hope for a change to CIII for the pure drug), but I'm not holding my breath.

I hope they AT LEAST make it so it can be CIII or CIV when mixed with APAP, ibuprofen, aspirin, etc.

The brand name will be Nucynta in the united states for tapentadol hydrochloride IR tablets (50 mg, 75 mg, or 100 mg).

On a positive note, the fact that it got hammered with a CII just like Vyvanse did means it showed CLEAR fun potential in the trials.

Source: http://www.deadiversion.usdoj.gov/fe...009/fr0217.htm

03-23-2009, 08:16 PM	#1
resorcinol Never Looked Back Join Date: Jul 2006 Location: NY(State), US, Earth (in 4 dimensions [length, width, depth, time]; maybe more beyond perception) Posts: 1,957	Tapentadol (Nucynta) placed in CII -- a sad... ...loss for hope of a little progressivism with scheduling for new psychoactive drugs. The drug is probably somewhere between hydrocodone and O-desmethyltramadol in potency as a mu agonist, so I guess if the DEA follows their own precedent this scheduling makes sense. However, it's such BS for those of us hoping for more lenient scheduling. It seems like the fuckheads at the DEA make anything with no dose ceiling that is an opioid or stimulant CII, period, despite the wide disparity in fun potential among CII drugs! PURE codeine and oxymorphone are in the same schedule (CII). Whoops, I was even mistaken above, an opioid prodrug DID find its way into CII (codeine by itself, no APAP or other add on drug in the formulation). That's just ridiculous. I was expecting CIII and hoping for CIV. When I saw that it got CII, I was floored. So much for patients just entering CP treatment having a drug option that has not yet been stigmatized to all hell by the media --- simply having CII attached to it is enough to spook doctors. It will be undergoing review / appeal (lets hope for a change to CIII for the pure drug), but I'm not holding my breath. I hope they AT LEAST make it so it can be CIII or CIV when mixed with APAP, ibuprofen, aspirin, etc. The brand name will be Nucynta in the united states for tapentadol hydrochloride IR tablets (50 mg, 75 mg, or 100 mg). On a positive note, the fact that it got hammered with a CII just like Vyvanse did means it showed CLEAR fun potential in the trials. Source: http://www.deadiversion.usdoj.gov/fe...009/fr0217.htm __________________ What, is there a pharmacy down there? -- Mia to Babi in Golden Sun while retrieving his Lemurian draught in Altmiller Cave

Thread Tools
Show Printable Version Email this Page
Display Modes
Switch to Linear Mode Switch to Hybrid Mode Threaded Mode